| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.1 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.1 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.1 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.061 | 0.1 |